Chief Scientific Officer · DiaMedica Therapeutics Inc. (DMAC)

Todd Verdoorn

A named executive officer of DiaMedica Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$423,382

Salary $221,667Stock awards $0

FY2017: $345,870

3rd of 3 named executive officers at DiaMedica Therapeutics by FY2018 total.

3 named officers on file for DiaMedica Therapeutics, FY2018

Todd Verdoorn’s pay file — $29

  • 2 fiscal years of pay, line by line
  • DMAC’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how DiaMedica Therapeutics’s whole pay program stands against its peers

  • DiaMedica Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on DMAC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2019 (DEF 14A).

Free

Get Todd Verdoorn’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Todd Verdoorn compensation by year

DiaMedica Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as DiaMedica Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$200,000$221,667
Bonus$40,000$0
Stock awards$0$0
Option awards$98,670$156,848
Non-equity incentive$0$36,000
Pension and deferred compensation$0$0
All other$7,200$8,867
Total$345,870$423,382

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DiaMedica Therapeutics Inc. DEF 14A filed April 8, 2019, accession 0001437749-19-006692, and prior-year filings.

How this page was built: the DiaMedica Therapeutics Inc. filed document, accession 0001437749-19-006692. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2019.

$346K
$423K
FY17
FY18
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option8,333—$5.20
Option12,500—$6.40
Option18,146—$11.20

Per the Outstanding Equity Awards at Fiscal Year-End table in DiaMedica Therapeutics Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

DiaMedica Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Rick PaulsPresident and Chief Executive Officer$733,707
Scott KellenChief Financial Officer and Secretary$642,921
Todd Verdoorn · this pageChief Scientific Officer$423,382

The full DiaMedica Therapeutics compensation record

free company brief

This page is one person within DiaMedica Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the DiaMedica Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are DiaMedica Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Todd Verdoorn's compensation dossier · One-time report. No refunds.